|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.94 CAD | -4.83% |
|
+0.25% | -0.25% |
| 09/05 | Transcript : HLS Therapeutics Inc., Q1 2024 Earnings Call, May 09, 2024 | |
| 09/05 | HLS Therapeutics Meets Q1 Earnings Forecast, But Misses on Revs; Lowers 2024 Vascepa Guidance | MT |
HLS Therapeutics Inc. announced that at its AGM held on June 16, 2023, the shareholders elected Christian Roy as director.
| 1st Jan change | Capi. | |
|---|---|---|
| -0.25% | 92.34M | |
| +21.93% | 73.38B | |
| -1.71% | 24.13B | |
| +7.33% | 8.78B | |
| +10.34% | 8.59B | |
| -19.80% | 8.06B | |
| +14.16% | 5.26B | |
| -0.03% | 4.21B | |
| +12.70% | 4.17B | |
| -2.54% | 3.89B |
HLS THERAPEUTICS INC. 
